Zebra Capital Management LLC Siga Technologies Inc Transaction History

Zebra Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.96 - $7.61 $147,480 - $188,309	-24,745 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$6.96 - $9.26 $19,369 - $25,770	-2,783 Reduced 10.11%	24,745 $186,000
Q3 2021 Nov 15, 2021	BUY	$5.71 - $7.39 $74,623 - $96,579	13,069 Added 90.39%	27,528 $204,000
Q1 2021 May 17, 2021	BUY	$6.3 - $7.71 $91,091 - $111,478	14,459 New	14,459 $94,000
Q3 2020 Nov 16, 2020	SELL	$5.62 - $7.68 $652,172 - $891,225	-116,045 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.55 - $6.19 $24,492 - $33,320	-5,383 Reduced 4.43%	116,045 $685,000
Q1 2020 May 15, 2020	SELL	$3.99 - $5.46 $80,889 - $110,690	-20,273 Reduced 14.31%	121,428 $580,000
Q4 2019 Feb 14, 2020	SELL	$4.34 - $5.86 $385,951 - $521,123	-88,929 Reduced 38.56%	141,701 $676,000
Q3 2019 Nov 14, 2019	BUY	$4.93 - $5.8 $861,463 - $1.01 Million	174,739 Added 312.64%	230,630 $1.18 Million
Q2 2019 Aug 14, 2019	BUY	$5.22 - $6.1 $207,072 - $241,980	39,669 Added 244.54%	55,891 $317,000
Q1 2019 May 15, 2019	BUY	$5.66 - $7.89 $91,816 - $127,991	16,222 New	16,222 $97,000

185

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $432M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.